Coley Fluid
WikiDoc Resources for Coley Fluid |
Articles |
---|
Most recent articles on Coley Fluid Most cited articles on Coley Fluid |
Media |
Powerpoint slides on Coley Fluid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Coley Fluid at Clinical Trials.gov Clinical Trials on Coley Fluid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Coley Fluid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Coley Fluid Discussion groups on Coley Fluid Patient Handouts on Coley Fluid Directions to Hospitals Treating Coley Fluid Risk calculators and risk factors for Coley Fluid
|
Healthcare Provider Resources |
Causes & Risk Factors for Coley Fluid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Coley Fluid is a modern reformulation of a historical cancer therapy called Coley Vaccine developed by Dr. William B. Coley that was an effective treatment for many forms of cancer including advanced breast cancer.
The authors of a 1982 study concluded five year survival rates of historical Coley Vaccine patients is indistinguishable from five-year survival of modern patients.
In 1999, researchers found ten-year survival was higher in historical Coley Vaccine patients compared to modern sarcoma, kidney and ovarian cancer patients.
Coley Fluid is manufactured by MBVax Bioscience Inc, Ancaster, Canada. Template:SIB